Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Colorcon
Medtronic
Harvard Business School
AstraZeneca
Boehringer Ingelheim
Mallinckrodt

Last Updated: October 20, 2019

DrugPatentWatch Database Preview

Drugs in Development Information for Aspartame

See Plans and Pricing

« Back to Dashboard

Drug Development Status for Aspartame: Sponsors, patents, clinical trial progress

Aspartame is an investigational drug.

There have been 5 clinical trials for Aspartame. The most recent clinical trial was a Phase 2 trial, which was initiated on June 10th 2019.

The most common disease conditions in clinical trials are Diabetes Mellitus, Hyperglycemia, and Obesity, Abdominal. The leading clinical trial sponsors are West China Hospital, Medical University of South Carolina, and University of Toronto.

There are two US patents protecting this investigational drug and thirty-four international patents.

Recent Clinical Trials for Aspartame
TitleSponsorPhase
Study of the Efficacy and Safety of Quiklean® and Klean-Prep With Dulcolax® for the Bowel Preparation Prior to ColonoscopyUniversal Integrated Corp.Phase 3
Effects of Fenofibrate Therapy in Diabetic NephropathyNational Medical Research Council (NMRC), SingaporePhase 3
Effects of Fenofibrate Therapy in Diabetic NephropathySingapore General HospitalPhase 3

See all Aspartame clinical trials

Clinical Trial Summary for Aspartame

Top disease conditions for Aspartame
Top clinical trial sponsors for Aspartame

See all Aspartame clinical trials

US Patents for Aspartame

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Aspartame   Start Trial Infusion methods and products Ocean Spray Cranberries, Inc. (Lakeville-Middleboro, MA)   Start Trial
Aspartame   Start Trial Cyclic boronic acid ester derivatives and methods of making the same Rempex Pharmaceuticals, Inc. (San Diego, CA)   Start Trial
Aspartame   Start Trial Pharmaceutical composition for preventing or treating skin cancer comprising Panax spp. plant extract and method of preventing or treating skin cancer in a subject using the same KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (Seoul, KR)   Start Trial
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Baxter
McKesson
AstraZeneca
McKinsey
Express Scripts
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.